<code id='1520B7539A'></code><style id='1520B7539A'></style>
    • <acronym id='1520B7539A'></acronym>
      <center id='1520B7539A'><center id='1520B7539A'><tfoot id='1520B7539A'></tfoot></center><abbr id='1520B7539A'><dir id='1520B7539A'><tfoot id='1520B7539A'></tfoot><noframes id='1520B7539A'>

    • <optgroup id='1520B7539A'><strike id='1520B7539A'><sup id='1520B7539A'></sup></strike><code id='1520B7539A'></code></optgroup>
        1. <b id='1520B7539A'><label id='1520B7539A'><select id='1520B7539A'><dt id='1520B7539A'><span id='1520B7539A'></span></dt></select></label></b><u id='1520B7539A'></u>
          <i id='1520B7539A'><strike id='1520B7539A'><tt id='1520B7539A'><pre id='1520B7539A'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:hotspot    Page View:27
          STAT

          What if CRISPR isn’t all that commercial? How does the NurOwn story end? And how do you pronounce “Bayer”?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Live from Boston at the 2023 STAT Summit, we discuss the latest news in the life sciences, including a milestone in genome editing, a twist in the search for ALS treatments, and the polarizing process of saying words in biotech.

          advertisement

          For more on what we cover, here’s the latest from the Summit; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          explore

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          Research misconduct: Proposed new rules face resistance
          Research misconduct: Proposed new rules face resistance

          AdobeResearchuniversitiesarevoicingconcernsoversomeproposedchangestotheprocessforreviewingscientific

          read more
          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more

          What we owe ALS patients — and why one company fell short

          MollyFergusonforSTATWhatdoyousaytoapatientwhentheFDArejects“their”experimentaldrug—onethattheybeliev